• Navigating policy issues that surround FDA approval of company's treatments for neurodegenerative diseases (like ALS, MS, and Parkinson's) through restoration and protection of nueronal health and function, including seeking regulatory flexibility through Accelerated Approval process.

Duration: January 1, 2024 to present

General Issues: Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Medicare/Medicaid

Spending: about $10,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2024: U.S. Senate, House of Representatives